Brown v. EI Dupont De Nemours & Co., Inc.

820 A.2d 362, 2003 Del. LEXIS 229, 2003 WL 1889881
CourtSupreme Court of Delaware
DecidedApril 15, 2003
Docket298, 2002, 299, 2002
StatusPublished
Cited by16 cases

This text of 820 A.2d 362 (Brown v. EI Dupont De Nemours & Co., Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brown v. EI Dupont De Nemours & Co., Inc., 820 A.2d 362, 2003 Del. LEXIS 229, 2003 WL 1889881 (Del. 2003).

Opinion

VEASEY, Chief Justice:

In this appeal, we hold that the statute of limitations for an alleged injury resulting from toxic exposure did not begin to run until the plaintiffs were on notice that the harmful effects of the toxic exposure were possibly caused by wrongful conduct. The infant victims in this case were born with eye conditions that their physicians originally believed were either genetic defects or natural occurrences. Years later, however, a medical expert linked the birth defects to prenatal exposure to a chemical produced by the defendant. It was not until then that the plaintiffs were on notice of a possible tortious act.

The applicable statute of limitations begins to run when injuries are “sustained.” We hold that the commencement of the limitations period here is deferred until the plaintiffs were on notice that the birth defects were potentially actionable injuries because legal injuries were not sustained until that time.

Facts

Eight families brought products liability claims against E.I. duPont de Nemours and Company, Inc. (“DuPont”) alleging that the exposure of pregnant mothers to Benlate, a DuPont product, caused birth defects in their children. 1 When the plaintiff children in this case were born, physicians diagnosed the defects as either ano-phthalmia or severe microphthalmia. The children suffering from anophthalmia were born without eyes. The children suffering from microphthalmia were born with abnormally small eyes. 2

*365 Shortly after the children were born, the parents sought a medical explanation for their children’s conditions. The doctors informed the parents that the cause of the birth defects was unknown. At the time, scholarship in the area suggested that ano-phthalmia and microphthalmia were either genetic defects or were caused by intrauterine infections. None of the doctors could find the condition in the parents’ family medical histories, however. The parents assumed the abnormalities were an act of nature.

In the Spring of 1996, an expert linked the children’s condition to their mothers’ prenatal exposure to benomyl, an active ingredient in Benlate, which is a fungicide produced by DuPont. This product is primarily used for commercial agricultural purposes. The plaintiffs contend that the mothers were exposed to Benlate during the periods in which they were pregnant by handling seedlings and flower bulbs either soaked or dusted with Benlate while the mothers were working in a nursery or tending to their home gardens.

Proceedings in the Superior Court

Two families brought a product liability action against DuPont on June 24, 1997. Four other families brought a similar action on July 15, 1997. The applicable statute of limitations period is two years from the date the injuries were sustained. 3 The plaintiffs contend that the complaints were filed less than two years after the families were on notice of the possible link between Benlate and the eye abnormalities, even though they were filed more than two years after each of the children was born. 4 The trial judge granted a motion for summary judgment in favor of DuPont and dismissed the actions of six of the Plaintiff families as time-barred by the statute of limitations. 5

Issue on Appeal

Plaintiffs argue that the trial judge erred by dismissing their cause of action as time-barred because the plaintiffs filed suit more than two years after the children were born. Although the statute requires a plaintiff to bring an action within two years of the time the “injury” is “sustained,” plaintiffs argue that the limitations period did not begin to run until the plaintiffs were on notice that the eye conditions might have been related to Benlate exposure.

The Limitations Period Did Not Begin to Run Until Plaintiffs Should Have Known that Benlate Could Have Caused the Birth Defects

The fate of the plaintiffs’ claims depends on the proper interpretation of Title 10, Section 8119 of the Delaware Code. Section 8119 bars any personal injury damage action that is “brought after the expiration of 2 years from the date upon which it is claimed that such alleged inju *366 ries were sustained!.]” 6 Although the “injuries” were physically “sustained” by the children in útero, the plaintiffs ask this Court to apply the time of discovery exception 7 to their actions on the ground that the “injuries” for purposes of Section 8119 were not “sustained” — and thus the two-year clock did not begin running — until 1996, when the plaintiffs were first on notice of a possible connection between the children’s eye conditions and their mothers’ exposure to Benlate.

Summary judgment in favor of DuPont may be granted only if the facts, viewed in a light most favorable to each of the plaintiffs, “predominate toward the conclusion that the plaintiff is chargeable with knowledge that his harmful physical condition was attributable” to DuPont’s product. 8 Plaintiffs contend that, until 1996, no one in the medical community had characterized the birth defects as possible tortious injuries. In accordance with the discovery exception, the trial judge should have determined that the statute of limitations did not start to run until the children’s parents were on notice that a legally actionable injury existed.

The Time of Discovery Exception Applies to the Plaintiffs’

Claims

Plaintiffs’ actions fall into a category of cases where Section 8119 does not operate perfectly. Normally, an “injury” is “sustained” when a wrongful act or omission occurs. 9 Situations arise, however, where the moment of the wrongful act and the plaintiffs discovery of the injury do not occur within close proximity of each other. In appropriate circumstances, this Court has applied an exception to the limitations period by interpreting it to run at the time the plaintiff is on notice that he or she has sustained a tortious injury. As we held in Layton v. Allen, Section 8119 is ambiguous because an “injury” is “sustained” either at the time the wrongful act is committed or at the time the plaintiff should have discovered the injury. 10

The discovery exception prevents the operation of Section 8119 from presenting the plaintiff with a Hobson’s choice. 11 The General Assembly could not reasonably have intended to “grant a remedy for a wrong but to bar the remedy before the wrong was physically ascertainable.” 12 Thus, in Layton v. Allen

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re: Zantac (Ranitidine) Litigation
Superior Court of Delaware, 2026
Bertola v. Fisher-Price
Superior Court of Delaware, 2025
West v. Patterson-Schwartz & Associates, Inc.
Superior Court of Delaware, 2024
Baker v. Croda Inc.
Supreme Court of Delaware, 2023
Baker v. Croda Inc.
D. Delaware, 2021
Bredberg v. Boston Scientific Corporation
Superior Court of Delaware, 2021
Personalized User Model, LLP v. Google Inc.
797 F.3d 1341 (Federal Circuit, 2015)
Evans v. Genentech, Inc.
Superior Court of Delaware, 2015
Dabaldo v. URS Energy & Construction
85 A.3d 73 (Supreme Court of Delaware, 2014)
Bowen v. EI DuPont De Nemours & Co., Inc.
906 A.2d 787 (Supreme Court of Delaware, 2006)
Brin v. S.E.W. Investors
902 A.2d 784 (District of Columbia Court of Appeals, 2006)
Bailey v. Khoury
891 So. 2d 1268 (Supreme Court of Louisiana, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
820 A.2d 362, 2003 Del. LEXIS 229, 2003 WL 1889881, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brown-v-ei-dupont-de-nemours-co-inc-del-2003.